George Frangeskides, Exec-Chair at Alba Mineral Resources, discusses grades at the Clogau Gold Mine. Watch the full video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksABC.L Regulatory News (ABC)

  • There is currently no data for ABC

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Total Voting Rights

1 Sep 2020 07:52

RNS Number : 6325X
ABCAM PLC
01 September 2020
 

For immediate release

01 September 2020

ABCAM PLC

("Abcam" or "Company")

Total Voting Rights - Voting Rights and Capital

 

In conformity with the Disclosure Rules and Transparency Rules, provision 5.6.1, the Company notifies the market of the following: The Company's issued share capital consists of 216,192,416 Ordinary Shares of 0.2p each with voting rights. The Company does not hold any shares in Treasury.The above figure of 216,192,416 may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in the Company under the FCA's Disclosure and Transparency Rules.

Date of Notification: 01 September 2020.

For further information please contact:

Abcam

+ 44 (0) 1223 696 000

Marc Perkins, Company Secretary

 

Numis - Nominated Adviser & Joint Corporate Broker

+ 44 (0) 20 7260 1000

Garry Levin / Huw Jeremy

 

J.P.Morgan Cazenove - Joint Corporate Broker

James Mitford / Hemant Kapoor

 

 

+44 (0) 20 7742 4000

 

Morgan Stanley - Joint Corporate Broker

Tom Perry / Luka Kezic

 

 

+44 (0) 20 425 8000

 

FTI Consulting

Ben Atwell / Natalie Garland-Collins

 

 

+44 (0) 20 3727 1000

Notes to Editors

About Abcam plc

As an innovator in reagents and tools, Abcam's purpose is to serve life science researchers globally to achieve their mission, faster. Providing the research and clinical communities with tools and scientific support, the Company offers highly validated biological binders and assays to address important targets in critical biological pathways.

 

Already a pioneer in data sharing and ecommerce in the life sciences, Abcam's ambition is to be the most influential company in life sciences by helping advance global understanding of biology and causes of disease, which, in turn, will drive new treatments and improved health. Two-thirds of the world's 750,000 life science researchers use Abcam's affinity binders, reagents, biomarkers and assays and the Company's products are mentioned in over 20,000 of the 56,000 peer-reviewed papers published each year in the life sciences.

 

By actively listening to and collaborating with researchers, the Company continuously advances its portfolio to address their needs. A transparent programme of customer reviews and datasheets, combined with an industry-leading validation initiative, gives researchers increased confidence in their results.

 

Abcam's thirteen locations are in the world's leading life science research hubs, enabling local services and multi-language support. Founded in 1998 and headquartered in Cambridge, UK, the Company sells to more than 100 countries. Abcam was admitted to AIM in 2005 (AIM: ABC).

 

To find out more, please visit www.abcam.com and www.abcamplc.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TVRUPUUABUPUUQG
Date   Source Headline
14th Dec 20227:00 amRNSCancellation - Abcam Plc
12th Dec 20228:00 amRNSUpdate on AIM Delisting
9th Dec 20225:30 pmRNSAbcam
8th Dec 20222:36 pmRNSHolding(s) in Company
30th Nov 20228:55 amRNSTotal Voting Rights
28th Nov 20222:21 pmRNSDirector/PDMR Shareholding - Correction
28th Nov 20222:21 pmRNSDirector/PDMR Shareholding - Correction
17th Nov 20223:59 pmRNSDirector/PDMR Shareholding
17th Nov 20223:57 pmRNSDirector/PDMR Shareholding
11th Nov 20223:30 pmRNSResult of General Meeting
31st Oct 20223:22 pmRNSTotal Voting Rights
17th Oct 20227:00 amRNSPropose cancellation of AIM shares notice of GM
17th Oct 20227:00 amRNSProposed cancellation of AIM shares & notice of GM
10th Oct 20224:45 pmRNSDirector/PDMR Shareholding
10th Oct 20222:01 pmRNSDirector/PDMR Shareholding
10th Oct 20221:59 pmRNSDirector/PDMR Shareholding
30th Sep 20223:50 pmRNSBlock Listing Six Monthly Return
30th Sep 20223:48 pmRNSTotal Voting Rights
12th Sep 202212:00 pmRNSInterim results for the period ended 30 June 2022
12th Sep 20227:00 amRNSAppointment of Non-Executive Director
1st Sep 20222:02 pmRNSAbcam attend Morgan Stanley Healthcare Conference
31st Aug 202211:16 amRNSTotal Voting Rights
17th Aug 20228:30 amRNSNotice of Results
29th Jul 202211:09 amRNSTotal Voting Rights
20th Jul 202212:00 pmRNSTrading Statement
4th Jul 20228:36 amRNSTotal Voting Rights
31st May 20224:22 pmRNSTotal Voting Rights
18th May 20224:30 pmRNSResult of AGM
3rd May 202212:41 pmRNSDirector/PDMR Shareholding
29th Apr 20224:01 pmRNSTotal Voting Rights
5th Apr 20224:35 pmRNSDirector/PDMR Shareholding
4th Apr 20227:00 amRNSPublication of 2021 ARA and Notice of AGM
31st Mar 202210:58 amRNSTotal Voting Rights
30th Mar 20222:41 pmRNSBlock listing Interim Review
28th Mar 20223:09 pmRNSBlock Listing application of Ordinary Shares
17th Mar 20221:18 pmRNSDirector/PDMR Shareholding Notification
14th Mar 202212:00 pmRNSResults for the period ended 31 December 2021
2nd Mar 20227:00 amRNSTotal Voting Rights
28th Feb 20227:00 amRNSNotice of Full Year Results
4th Feb 202212:02 pmRNSDirector/PDMR Shareholding
31st Jan 202211:49 amRNSTotal Voting Rights
27th Jan 202212:00 pmRNSTrading Statement
31st Dec 202112:49 pmRNSTotal Voting Rights
2nd Dec 20217:00 amRNSUpdate on 2021 General Meeting Resolution Vote
30th Nov 20213:25 pmRNSTotal Voting Rights
12th Nov 20215:28 pmRNSIssue of Equity and Replacement PDMR Notification
12th Nov 20214:17 pmRNSTotal Voting Rights
12th Nov 202112:34 pmRNSIssue of Equity and Replacement PDMR Notification
10th Nov 20214:56 pmRNSIssue of Equity and PDMR Notification
5th Nov 20213:19 pmRNSVesting of All Employee Share Scheme

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.